1.Shen D#, Wang X, Wang H, Xu G, Xie Y, Zhuang Z, Huang Z, Li J, Lin J, Wang P, Huang M, Luo Y, Yu H*. Current Surveillance After Treatment is Not Sufficient for Patients With Rectal Cancer With Negative Baseline CEA. Journal of the National Comprehensive Cancer Network. 2022 Mar 1:1-10. 2.Cao X#, Li W, Wang T, Ran D, Davalos V, Planas-Serra L, Pujol A, Esteller M, Wang X, Yu H*. Accelerated biological aging in COVID-19 patients. Nat Commun. 2022 Apr 19;13(1):2135. 3.Zou Q#, Wang X#, Ren D#, Hu B, Tang G, Zhang Y, Huang M, Pai RK, Buchanan DD, Win AK, Newcomb PA, Grady WM, Yu H*, Luo Y*. DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer. J Immunother Cancer. 2021;9. 4.Wang X#, Chen S#, Zhao Z, Chen F, Huang Y, Guo X, Lei L, Wang W, Luo Y, Yu H*, Wang J*. Genomic G-quadruplex Folding Triggers a Cytokine-mediated Inflammatory Feedback Loop to Aggravate Inflammatory Diseases. iScience. 2022. 5.Xie Y#, Lin J#, Zhang N#, Wang X, Wang P, Peng S, Li J, Wu Y, Huang Y, Zhuang Z, Shen D, Zhu M, Liu X, Liu G, Meng X, Huang M, Yu H*, Luo Y*. Prevalent Pseudoprogression and Pseudoresidue in Rectal Cancer Patients Treated with Neoadjuvant Immune Checkpoint Inhibitors. Journal of the National Comprehensive Cancer Network. 2022. 6.Yu H#, Wang X, Bai L, Tang G, Carter KT, Cui J, Huang P, Liang L, Ding Y, Cai M, Huang M, Liu H, Cao G, Gallinger S, Pai RK, Buchanan DD, Win AK, Newcomb PA, Wang JP*, Grady WM*, Luo Y*. DNA Methylation Profile in CpG-depleted Genomic Region Uncovers an Epigenetic Subtype with High Risk of Recurrence in Early-stage Colorectal Cancer. J Natl Cancer Inst. 2022. 7.Yu H#, Luo Y*. Decentered Crowdfunded Clinical Studies-Open a New Era of Medical Research. JAMA Oncol. 2019;5:9-10. 8.Yu H#, Bai L, Tang G, Wang X, Huang M, Cao G, Wang J, Luo Y*. Novel Assay for Quantitative Analysis of DNA Methylation at Single-Base Resolution. Clin Chem. 2019;65:664-673.